In this study, doctors from South Korea compared upper gastrointestinal (UGI) series and endoscopy in the diagnosis and localization of scirrhous gastric carcinoma.
The team included 72 patients with pathologically proven scirrhous gastric carcinoma.
They compared preoperative reports at UGI series and endoscopic examination. These included data on the location and extent of the tumor
|33% of the endoscopic reports and 68% of the UGI series reports were correct.|
The team compared these with pathology reports, and the accuracy of the preoperative reports was calculated.
The doctors found that diagnoses at endoscopy were Borrmann type IV carcinoma in 39%, type III carcinoma 40%, early gastric carcinoma 10%, lymphoma 8%, atrophic gastritis 3%, and type II carcinoma 3%.
Diagnosis at UGI series revealed type IV carcinoma in 61%, type III carcinoma 35%, lymphoma 3%, and early gastric carcinoma 1%.
The team determined that reports of tumor location and extent were correct in 33% of the endoscopic reports and 68% of the UGI series reports.
In 68 patients, UGI series revealed thickened and irregular folds in 91%, ulceration in 62%, and nodularity in 32% at consensus review.
Endoscopic biopsy samples were positive for malignancy in 93% of patients.
Dr Mi-Suk Park and colleagues concluded, "UGI series is superior to endoscopic examination in the diagnosis and localization of scirrhous gastric carcinoma".